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Extracellular acidification occurs in the brain with elevated neural activity, increased metabolism, and neuronal
injury. This reduction in pH can have profound effects on brain function because pH regulates essentially every
single biochemical reaction. Therefore, it is not surprising to see that Nature evolves a family of proteins, the
acid-sensing ion channels (ASICs), to sense extracellular pH reduction. ASICs are proton-gated cation channels that
are mainly expressed in the nervous system. In recent years, a growing body of literature has shown that acidosis,
through activating ASICs, contributes to multiple diseases, including ischemia, multiple sclerosis, and seizures. In
addition, ASICs play a key role in fear and anxiety related psychiatric disorders. Several recent reviews have
summarized the importance and therapeutic potential of ASICs in neurological diseases, as well as the
structure-function relationship of ASICs. However, there is little focused coverage on either the basic biology of
ASICs or their contribution to neural plasticity. This review will center on these topics, with an emphasis on the
synaptic role of ASICs and molecular mechanisms regulating the spatial distribution and function of these ion
channels.
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Acid-sensing ion channels (ASICs) are a family of
proton-gated cation channels which are expressed pri-
marily in the nervous system [1,2]. ASICs belong to a
superfamily which also contains degenerins (DEG) and
epithelial sodium channels (ENaC). All members within
the ENaC/DEG/ASIC (EDA) superfamily share the same
topology, with the N- and C-termini located inside the
cell and a large well organized, cysteine-rich extracellular
domain [1,2]. There are four genes encoding at least six
different ASICs (Table 1). ASICs function as trimers
[3,4] and conduct mostly Na+. Homomeric ASIC1a and
human ASIC1b, as well as ASIC1a/2b heteromers, also
have a low permeability to Ca2+ [5-9]. Interestingly, at
pH 7.25 (but not at pH 5.5), a complex between a trun-
cated chick ASIC1 and Psalmotoxin (PcTx1) is non-
selective to monovalent cations [10]. This result indi-
cates that ion selectivity of ASICs can be altered underCorrespondence: zha@southalabama.edu
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reproduction in any medium, provided the orspecific conditions. ASIC1 and ASIC3 start to open at
about pH 7 and 7.2, respectively, which enables them to
sense pH changes within physiological pH ranges [5,11-15].
In addition, a recent study shows that human ASIC3 can
also respond to alkanization [16]. Since extracellular pH
fluctuation is common in pathological conditions, it is con-
ceivable that ASICs play important roles in a wide
spectrum of neurological diseases. Consistent with this
speculation, ASICs contribute to pain, brain ischemia, mul-
tiple sclerosis, seizures as well as anxiety-related disorders
[1,2,17,18]. These findings highlight the potential thera-
peutic value of targeting ASICs in diseases. In addition, re-
cent studies reveal that ASICs and acidosis regulate
dendritic spines, the site of most excitatory neurotransmis-
sion in the brain [19-21]. These data suggest that ASICs
also play an important role in regulating neural plasticity in
pathological conditions.Recent advances in ASIC pharmacology
Although the canonical ligand for ASICs is protons, the
massive extracellular domain of ASICs has led to the
speculation that these receptors may also respond tois an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Basic channel properties, activators and inhibitors of ASICs
Gene Protein pH50 Agonist (EC50) Antagonist (IC50) Ions passed References




ASIC1b ~6.0 (mouse) MitTx (23 nM) Mambalgin (192 nM) mouse: Na+
human: Na+ > Ca2+
[6,7,12,13,22,24,28]
~6.2 (human)
ASIC2 (ACCN1) ASIC2a 4.5–4.9 Minimal activa-tion by MitTx A-317567 (29 μM) Na+ [12,15,22,25,29-31]
ASIC2b N/A – [29-31]
ASIC3 ASIC3 ~6.6 GMQ (0.35 mM) APETx2 (63 nM) Na+ [13,22,25,32-36]
MitTx (830 nM) Sevanol (0.35 mM)
A-317567 (9.5 μM)
ASIC4 ASIC4 N/A – [37]
Heteromeric channels 1a + 1b 6.0 Mambalgin (72 nM) Na+ [15]
1a + 2a 5.5–6.1 Mambalgin (246 nM) Na+ [12,15,24,26]
1a + 2b Same as ASIC1a Mambalgin (61 nM)
PcTx1 (~3 nM)
Na+ > Ca2+ [9,15,24]
1a + 3 6.3–6,6 Na+ [12,15]
1b + 3 6.0 Na+ [15]
1b + 2a 4.9 Na+ [15]
2a + 3 5.7–6.1 Na+ [12,15]
2b + 3 6.5 APETx2 (117 nM) Na+ [15,33,36]
Note: amiloride is not included in the table because it functions as a universal blocker for ASICs and many other ion channels, such as ENaCs and sodium/
hydrogen exchangers.
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channels are potentiated by FMRFmide like peptides,
dynorphin A and big dynorphin; all reduce the steady-
state desensitization of ASICs [39-41]. In addition,
spermine, a polyamine that is released in injury condi-
tions, also potentiates ASIC currents by reducing the
steady-state desensitization [11,42]. These studies, along
with the link between ASICs and multiple diseases, have
inspired the screening for novel ASIC ligands/antago-
nists using various approaches. The first non-proton
ligand identified is 2-guanidine-4-methylquinazoline
(GMQ), which activates ASIC3 at normal pH [32]. In
addition, Bohlen et al. recently isolated a peptide, MitTx,
from the venom of Texas coral snake [22]. At neutral
pH, MitTx induces sustained opening of ASICs, and is
highly selective to ASIC1 (see Table 1). These findings
not only provide novel tools for studying ASIC function
but also suggest that physiological ligands other than
protons exist.
Various ASIC inhibitors have also been isolated from
venoms. PcTx1, a toxin isolated from the venom of tar-
antula spider, is specific to ASIC1a homomeric and
ASIC1a/2b heteromeric channels [9,23]. APETx2, on the
other hand, inhibits ASIC3 containing channels [33]. Re-
cently, another class of peptides, named mambalgins,
were isolated from black mamba venom; mambalginsinhibit several ASICs and abolish pain sensation [24].
Besides these peptides, several small molecules also in-
hibit ASICs. One commonly used small molecule inhibi-
tor is amiloride. Though unspecific, amiloride has the
advantage in that it has been used clinically for decades.
A-317567 is a synthetic compound which inhibits
ASIC1a, 2a and 3 [25]. Sevanol, or epiphyllic acid 9, 10-
diisocitryl ester, isolated from a plant, Thymus armenia-
cus, inhibits both ASIC3 and ASIC1a, with no effect on
other ASIC subunits [34]. A summary of these ASIC
activators and inhibitors is presented in Table 1. These
reagents are useful for manipulating ASIC activities in
functional studies. However, the development of add-
itional subunit-specific pharmacological inhibitors will
be valuable for targeting of ASICs in diseases.
Expression and subcellular localization of ASICs
Overall expression of ASICs
The distribution of ASIC mRNA is wide spread at both
peripheral and central nervous systems (PNS and CNS).
The PNS expresses all ASIC subunits [5,7,29-31,35,43].
The CNS, on the other hand, primarily expresses
ASIC1a, ASIC2a, and ASIC2b [29-31,35]. Almost all
neurons possess robust acid-evoked ASIC type current
[44-47]. Other than neurons, NG2 glia cells [48], some
receptor cells [49-52], vascular smooth muscle [53], and
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at lower levels. In addition, many types of brain tumors
upregulate ASIC expression [55,56], which suggests a
possible role of ASICs in tumor physiology.
Consistent with the in situ and PCR results, western
blot and immunostaining detect ASIC1a protein in most
brain regions. However, there are variations in the rela-
tive expression level of ASIC1a among different struc-
tures. ASIC1a levels are higher in amygdala, cingulate,
periaqueductal gray, layer III of somatosensory cortex
and striatum [57-59]. Within the hippocampus, the den-
tate gyrus region shows higher ASIC1 immunostaining
than CA1 and CA3 [59]. Detailed localization of en-
dogenous ASIC2 protein is not yet available, largely
due to the lack of a reliable ASIC2 antibody for
detecting endogenous ASIC2 proteins [20,52]. How-
ever, most of the currents recorded from CNS
neurons show a mixed contribution from ASIC1a
homomeric, ASIC1a/2a, and ASIC1a/2b heteromeric
channels [9,45,46,58,60-62]. In addition, the properties
of acid-activated current recorded suggest that the
relative expression of ASIC2 varies among different
brain regions. For example, currents in medium spiny
neurons in striatum contain a predominant ASIC1a
homomeric component [61]. Similarly, cerebellar Pur-
kinje cells exhibit currents representative of ASIC1a
homomers or 1a/2b heteromers [60]. In hippocampus,
the basket cells, one class of interneuron, expresses
primarily ASIC1a while many other interneurons ex-
press both ASIC1a and ASIC2 [47].
Besides the variation among brain regions and cell
types, there may also be developmental changes in
ASIC expression. In one study, increased maturation
of the neuronal culture is associated with increased
ASIC2:ASIC1a mRNA ratio and reduced inhibition of
ASIC currents by PcTx1 [63], suggesting that the rela-
tive ASIC2 protein levels are increased with matur-
ation/aging. There may also exist species differences.
In cultured human cortical neurons, acid-activated
currents appear to come predominantly from ASIC1a
homomers [64]. In contrast, currents in mouse/rat
neurons typically exhibit a higher contribution from
ASIC1a/ASIC2 heteromers. This difference is interest-
ing. However, in the human study, neurons were iso-
lated from patients of 23–72 years old and recorded
at 3–4 days in culture [64]. Most rodent studies, on
the other hand, were performed on neurons obtained
from embryonic or early postnatal animals and cul-
tured for 7–21 days. Therefore, caution shall be taken
as to whether the differences observed are completely
attributable to species. Nevertheless, these results in-
dicate that it will be important to study the biogen-
esis and function of human ASICs, preferably in
human neurons.Subcellular localization of ASICs in neurons
In peripheral neurons, ASIC1, 2, and 3 are detected in
axons, axon terminals and cell bodies [43,65,66]. In the
brain, both ASIC1a and ASIC2a show a preferential
somatodendritic distribution [67-69]. In cultured CNS
neurons, endogenous ASIC1a localizes primarily to den-
drites with little detectable presence in axons [19,44,70].
Similar distribution is observed when ASIC1a and
ASIC2a are expressed in organotypic hippocampal slices
[19-21,71]. Of note, one previous study reports a ubiqui-
tous distribution of ASIC1 in cultured brain neurons
[57]. The reason for this discrepancy is unclear, although
it is noted that the antibodies used in the above studies
are different. The healthiness of the neuron also regu-
lates ASIC localization. In spinal cord, endogenous
ASIC1a is barely detectable in healthy axons, but
increases drastically when the axons are injured [72].
Taken together, these data demonstrate a preferential
somatodendritic targeting of ASIC1a in CNS, and sug-
gests that altered subcellular traffficking of ASICs plays
a critical role in pathological conditions.
Besides the immunostaining results, biochemical analysis
shows that ASIC1a and ASIC2a are enriched in brain
synaptosomes [20,44,69]. Together, these data suggest an
increased postsynaptic trafficking of ASICs. Consistent with
this speculation, ASIC1a shows punctate staining along the
dendrites in cultured brain neurons, which indicates that
ASIC1a is clustered in dendritic spines (Figure 1A). To ob-
tain high resolution images and study ASIC localization in
a more physiological environment, we transfected epitope
tagged ASIC1a and ASIC2a into organotypic hippocampal
slices. Both ASIC1a and ASIC2a are present in most den-
dritic spines in slice neurons [19-21,71]. In addition, the
relative level of ASIC1a in spines is higher as compared to
that of a membrane-targeted Lck-GFP, demonstrating that
ASIC1a is enriched in dendritic spines (Figure 1B). These
data indicate a preferential trafficking of ASIC1a and
ASIC2a to the postsynaptic membrane.
Synaptic and dendritic targeting of ASIC1a is further
supported by electrophysiological recordings and Ca2+ im-
aging experiments. Puffing acidic solutions to dendritic re-
gion elicits typical ASIC-type currents in hippocampal
slice neurons [47]. In addition, using cameleon as a
Ca2+ sensor, we have imaged acid-induced Ca2+ changes
in hippocampal slices [19,20]. Acidic stimulation leads
to a rapid increase of intracellular Ca2+ concentration
([Ca2+]i) in dendritic spines, dendrites and cell bodies of
pyramidal neurons (Figure 2A). The response is abolished
in ASIC1a−/− slice neurons and reduced in ASIC2−/−
slice neurons. These functional results, together with the
immunolocalization and biochemical data, demonstrate
that endogenous ASICs are not only preferentially traf-
ficked to dendrites and spines but also function as the
postsynaptic proton receptor there.
Figure 1 ASIC1a localization in dendritic spines. A) Immunofluorescence images showing the localization of endogenous ASIC1a in cultured
neurons. Wild type (WT) and ASIC1a−/− cortical neurons were stained with an anti-ASIC1a antibody. Inset at the bottom shows a high
magnification view of the boxed region in WT. Note the punctate staining along the dendrite, suggesting the presence of ASIC1a in dendritic
spines. B) Confocal images showing the enrichment of ASIC1a in spines of slice neurons. Organotypic hippocampal slices were transfected with
HA-ASIC1a and a membrane-targeted Lck-GFP. ASIC1a localization was detected by immunostaining with an anti-HA antibody. Plot on the right
shows the relative fluorescence intensity of ASIC1a and Lck-GFP along the line drawn on the merged image. ASIC1a shows a higher relative
spine:shaft signal as compared to Lck-GFP, demonstrating that ASIC1a preferentially traffics to dendritic spines. Data adapted from [19,21].
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Mechanisms by which ASIC activation increases [Ca2+]i
As stated above, ASIC activation mediates acidosis-
induced [Ca2+]i rise in neurons. Part of this Ca
2+ increase
is due to direct Ca2+ entry through ASIC1a containing
channels [73]. However, the relative permeability of Ca2+
is low: pNa+/pCa2+ is 2.5, 18.5 and 25 in three studies on
ASIC1a homomers [5,7,8], and ~4.1 for ASIC1a/2b het-
eromers [9]. Consistent with these data, several studies
show that most of acidosis-induced [Ca2+]i increase in
neurons are likely due to secondary mechanisms. In hip-
pocampal slices, replacing extracellular Na+ with NMDG
reduced acidic stimulation-induced [Ca2+]i rise by ~86%,
showing that Na+ influx through ASICs is important [19].
In chick dorsal root ganglion neurons, direct Ca2+ entryFigure 2 Mechanisms by which protons increase [Ca2+]i. A) Ca
2+ imagi
dendritic spines. Organotypic hippocampal slices were transfected with cam
overview of the imaged dendritic segment. Right ratiometric images show
and during acidic stimulation. Note the increase in Ca2+ in the dendrite an
how protons lead to [Ca2+]i increase in neurons. See text for detailed expla
acidosis can alter neural plasticity or, when [Ca2+]i passes certain thresholdthrough ASICs also contributes little to acid-induced Ca2+
increase [74]. Moreover, clamping the membrane potential
at −70 mV abolishes acidosis-induced [Ca2+]i increase in
cortical neurons [75], and inhibiting voltage-gated Ca2+
channels (VGCCs) largely eliminates acidosis-induced
Ca2+ increase [19,75].
These data suggest the following model (Figure 2B):
acidosis activates ASIC channels; Na+ along with a small
number of Ca2+ enters the cell, which lead to membrane
depolarization; then VGCCs get activated and initiate
the main Ca2+ influx. This conclusion is important for
understanding how ASICs impact neuron physiology.
It suggests that non-calcium permeable ASIC channels,
e.g., ASIC1a/2a heteromers, can make a significant contri-
bution to acidosis-induced [Ca2+]i responses. Supportingng showing acidosis-induced [Ca2+]i increase in dendrites and
eleon and stimulated with a pH 6.0 solution. Left image shows the
YFP/CFP ratio (red indicates high while blue indicates low Ca2+) before
d most dendritic spines. Data adapted from [20]. B) Drawing showing
nation. Depending on the magnitude and duration of the Ca2+ rise,
level, lead to neuronal injury.
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away both ASIC1a/2a and ASIC1a/2b heteromers, signifi-
cantly reduces acidosis-induced Ca2+ rise [20]. This model
also argues that when considering the effect of acidosis,
the number of functional ASIC channels is important as
opposed to the number of “Ca2+-conducting” populations.
Other downstream molecules are also involved in re-
sponse to acidosis and ASIC activation. Besides VGCCs,
store-operated release and sigma receptors also contrib-
ute to H+-induced [Ca2+]i increase in hippocampal slice
neurons and dissociated cortical neurons, respectively
[19,75]. CaMKII phosphorylation is also affected by
altered ASIC1a expression. Brains isolated from ASIC1a
null mice show a reduced CaMKII phosphorylation
while those from the transgenic mice overexpressing
ASIC1a have increased CaMKII phosphorylation [19].
This result suggests that manipulating ASIC1a expres-
sion level, and presumably ASIC activity, is sufficient to
regulate Ca2+ signaling in vivo. How ASICs get activated
in physiological conditions remains unclear. However,
with functional magnetic resonance imaging, one recent
report shows that learning induces acidification in
human brain [76]. Although the exact magnitude of pH
reduction in this paradigm remains to be determined,
this study provides a direct support for potential ASIC
activation by protons in physiological conditions.
ASIC and synaptic function
Their presence in dendritic spines suggests that ASICs
regulate synaptic physiology. Several studies have tested
this hypothesis in various systems. In hippocampal neu-
rons, deleting the ASIC1a gene has no effect on basal
levels of GABA, AMPA and NMDA currents [44,77].
However, ASIC1a deletion decreases the ratio of AMPA:
NMDA currents in microisland hippocampal cultures
[77]. Also in the microisland culture system, deleting the
ASIC1a gene reduces paired-pulse responses. This result
is consistent with a reduced long term potentiation in
the ASIC1a knockout [44], and suggests that activation
of ASICs contributes to increased synaptic efficacy in
these conditions. One intriguing finding is that deleting
the ASIC1a gene or inhibiting ASIC1a increases the fre-
quency of miniature excitatory postsynaptic potentials in
the microisland cultured neurons [77]. The mechanism
for this observation remains unclear, but may indicate
a possible feedback regulation as a consequence of
reduced ASIC activity.
The exact role of ASIC1a at synapses may also depend
on the experimental system studied. In contrast to the
results in slices and cultured hippocampal neurons, inhi-
biting ASIC1a or silencing ASIC1a with siRNA in retina
reduces photopic (cone-mediated) electroretinogram
(ERG), but had little effect on scotopic (rod-mediated)
ERG [78]. Deleting the ASIC2 gene, on the other hand,increases scotopic ERG in response to mid- to high-
intensity light, but has no effect on photopic ERG [52].
Despite the differential contribution of ASIC1a and ASIC2
in the rod and cone pathways, ASIC activation in both
cases appears to be inhibitory on neurotransmission.
These electrophysiological findings are consistent with
the synaptic localization of ASICs, and indicate that ASIC
activation affects synaptic physiology. One pivotal ques-
tion here is what is the contribution of ASICs to synaptic
transmission, either in physiological or pathophysiological
conditions. However, attempts to record an ASIC-initiated
current during synaptic transmission have been unsuc-
cessful [57]. This could be due to technical reasons. For
example, H+ are buffered fast, which may impose difficulty
for detecting small ASIC-generated synaptic currents
when record at the cell body. The rapid desensitization of
ASICs also adds technical challenges for detecting an
ASIC specific contribution. Interestingly, one recent study
shows that high frequency acidic stimulation can abolish
the desensitization of ASIC1a, suggesting prolonged ASIC
activation under similar conditions [79]. This result raises
the possibility that, with further tweaking of the experi-
mental protocol, along with the novel tools recently
developed (e.g. the specific pharmacological reagents),
one may uncover a specific contribution of ASICs to
neurotransmission.
ASICs, acidosis and spine remodeling
In addition to the effects on synaptic physiology, ASICs
also regulate structural remodeling of synaptic sites. In
hippocampal slice neurons, both transient and chronic
overexpression of human ASIC1a increases the number
and length of dendritic spines [19]. Conversely,
knockdown of ASIC1a with siRNA or expressing a
dominant-negative ASIC1a construct reduces spine
numbers. Deleting the ASIC2 gene, which decreases syn-
aptic targeting of ASIC1a, reduces the density of spine
synapses [20]. These results show a good correlation
between ASIC1a expression/synaptic levels and spine
density. However, deleting the ASIC1a gene has no
significant effect on dendritic spines [19]. The reason for
this result is unclear. One possible, though not easy to
test, explanation is that developmental compensation in
the chronic knockout model leads to the lack of an effect
in ASIC1a null slices. Another somewhat controversial
finding is that overexpressing a mouse ASIC1a has no
significant effect on spine number or length [21], which
contrasts with the increased spine density observed with
human ASIC1a overexpression. It is possible that the
intrinsic difference between human and mouse ASIC1a
is the cause. Supporting this speculation, human ASIC1a
shows larger acid-activated current and is less suscep-
tible to steady-state desensitization when compared to
mouse ASIC1a [21,40]. Another possible contributing
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slices were studied at the age equivalent to 17 days
old, which is more mature than the 13 day old culture in
Zha et al. [19]. In the literature, there are precedents that
the effect on spines depends upon the developmental
stages. One such example is A kinase anchor protein
150 (AKAP150). Disrupting the AKAP150 gene increases
spine density at 2 weeks of age but this effect is not seen
in adult stage [80]. Further study is needed to test these
possibilities. Nevertheless, current data demonstrate that
ASICs play an essential role in spine morphogenesis and/
or maintenance.
The results above further suggest that acidosis,
through activating ASICs, regulates spines/synapses. In-
deed, treating organotypic hippocampal slices with a pH
6 buffer reduces the density and length of dendritic
spines in a time-dependent manner [21]. As expected,
deleting the ASIC1a gene abolishes acidosis-induced
spine loss. These data reveal that, in addition to the “ca-
nonical” neurotoxic effect (see next section), acidosis
also modulates synaptic remodeling.
Given the fact that acidosis typically lasts for some
time in diseases, the above finding suggests that acidosis
contributes to the change in brain plasticity in patho-
logical conditions. However, several important questions
remain to be answered. First, in Jing et al., spine remod-
eling was induced by 1 hr incubation in medium buf-
fered at pH 6 [21]. Although a pH reduction to 6.0 or
even lower occurs in conditions like severe ischemia, the
duration in those cases is probably shorter, about 15–30
minutes [81]. However, a pH reduction to ~ pH 6.5
lasted for hours following middle cerebral artery occlu-
sion (MCAO) [82]. Therefore, it is necessary to answer
whether a persistent milder acidosis affects spines. It will
also be interesting to reveal the effect of acute acidosis
on spine dynamics. Timelapse experiments in vitro and
in vivo will be valuable in addressing these questions. In
addition, it will be important to ask whether acidosis
contributes to spine remodeling in diseases, e.g., ische-
mia or seizures, which are known to reduce dendritic
spines [83,84]. In parallel with the changes in spine
morphology, it will also be important to ask what effect
acidosis has on synaptic physiology, including plasticity.
Answers to these questions will be pivotal for our under-
standing of how acidosis and ASICs regulate synaptic
plasticity in diseases.
ASIC activation and neuronal injury
Through increasing [Ca2+]i, acidosis can lead to neuronal
injury (Figure 2B). This mechanism apparently contri-
butes to a major part of ischemia-induced neuronal
death [73,82,85,86]. In the MCAO model of brain ische-
mia, deleting the ASIC1a gene reduces MCAO-induced
infarct volume [42,73,82]. Besides ischemia, deletingASIC1a also slows down the disease progression in an
experimental autoimmune encephalomyelitis model [54].
These data indicate that ASIC1a activation exacerbates
neuronal injury in certain disease paradigms. ASIC acti-
vation can also be beneficial. For example, the activation
of ASIC1a is required for attenuating seizure progres-
sion; deleting the ASIC1a gene or inhibiting ASIC1a
increases seizure severity [87]. Similar mechanism may
also apply to other systems. In retina, deleting the ASIC2
gene increases the susceptibility of retina neurons to
bright illumination-induced damage [52]. In ASIC2−/−
but not wild-type retina, the outer and inner nuclear
layers, ganglion cell layer, and pigmented epithelium all
show increased apoptosis following a two-hour challenge
with bright light.
The results on seizure and light-induced retina dam-
age appear counterintuitive at the first sight, because
ASIC activation leads to increased [Ca2+]i and neuronal
firing, which typically leads to excitotoxicity. However,
ASICs are expressed in both excitatory and inhibitory
neurons. As a matter of fact, many interneurons exhibit
higher ASIC currents as compared to pyramidal neurons
[47,87,88]. Therefore, through differential activation of
excitatory or inhibitory neurons, acidosis can increase or
attenuate the excitability of the whole network. This
model will be an interesting one to test in future studies.
However, both inhibitory and excitatory neurons show
mixed expression of ASIC1a homomeric and ASIC1a/2a
heteromeric channels [47], suggesting that selective
pharmacological interventions to inhibit only interneur-
ons or only pyramidal neurons will be difficult. One pos-
sible approach is to genetically delete ASICs in either
inhibitory or excitatory neurons, and assess the outcome
in various neurological diseases.Molecular mechanisms regulating ASIC trafficking and
function
ASIC1a trafficking on neuronal injury and spine remodeling
Increased ASIC1a surface trafficking or channel activity
potentiates acidosis-induced neuronal death [41,42] and
leads to hyperalgesia in response to mechanical stimula-
tion [89]. These results indicate that the forward traffick-
ing of ASICs is critical for acidosis-induced neuronal
injury. Besides surface expression, trafficking to dendritic
regions may also be important for acidosis-induced
changes. An ASIC1a mutant with increased dendritic
and surface levels potentiates acidosis-induced spine loss
[21]. Conversely, an ASIC1a mutant with reduced traf-
ficking has the opposite effect. Since both mutants affect
both surface levels and dendritic targeting, it is difficult
to conclude whether the effect observed is due to den-
dritic ASIC1a specifically. Nevertheless, these data sup-
port the speculation that dendritically targeted ASIC1a
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of acidosis on spine remodeling.
The above data on ASIC trafficking are based on static
images/samples before and after treatment. To better
understand the mechanism, it will be important to
visualize real-time movement of ASICs following inter-
ventions. For example, how do changes in neural activity
affect ASIC trafficking, either to and from cell surface,
or to synaptic sites? How do disease conditions, e.g.,
increased ROS production, regulate ASIC trafficking in
live neurons? To address these questions, specific anti-
bodies recognizing extracellular domain of ASICs are
needed. Alternatively, one may introduce extracellularly
tagged ASICs into neurons. However, it is important to
note that, probably due to the complexity of its extra-
cellular domain, inserting extracellular tags typically
impairs the trafficking of ASICs ([90] and our own
experience).
N-glycosylation regulates ASIC trafficking and function
As one step toward understanding ASIC trafficking, re-
cent studies have assessed the role of N-glycosylation in
ASIC biogenesis. In both heterologous cells and brain
slices, surface ASIC1a contains a higher percentage of
EndoH-resistant population, which indicates that their
N-linked glycans have been further processed (or
“matured”) in mid-late Golgi [21,71]. Although the mat-
uration of N-linked glycans is not required for ASIC1a
surface expression, matured ASIC1a apparently traffics
preferentially to the cell surface. Tunicamycin, which
inhibits the addition of N-linked sugars [91], reduces
ASIC1a surface levels [21]. In addition, tunicamycin
decreases dendritic targeting of ASIC1a in hippocampal
slices, and reduces both the amplitude and desen-
sitization rate of ASIC1a current in CHO cells. These
data indicate that the maturation of N-glycans on ASICs
is important for their proper spatial distribution and
channel function.
The number of potential N-glycosylation sites in dif-
ferent ASIC subunits ranges from two to four, with
ASIC1a and 2a each contains two. Both of the two po-
tential glycosylation sites on ASIC1a and ASIC2a are
glycosylated in heterologous cells [71,90,92]. Two separ-
ate studies have assessed the effect of glycosylation
mutants on ASIC1a channel properties [71,90]. Mutating
the Asn393 site reduces ASIC1a maturation and acid-
activated current. One note to make is that the Asn393
site, which locates between the α6 and α7 helices in the
crystal structure, is conserved in all ASICs [4]. It will be
interesting to ask whether the glycosylation of this site
has similar effect in other subunits. Unlike Asn393, the
effect of Asn366 mutation differs between the two pub-
lished studies. In an earlier study, a rat N366A mutant
reduces acid-activated current in Xenopus oocytes [90].In contrast, we found that mutating the Asn366 site in
either mouse or rat ASIC1a increases surface expression
and pH-activated current in both CHO cells and Xen-
opus oocytes [71]. In our study, the mouse N366Q mu-
tant also shows increased dendritic targeting in
hippocampal slices, and when compared to WT ASIC1a,
N366Q further potentiates acidosis-induced spine loss;
both observations are consistent with an increased traf-
ficking of the N366Q mutant. While the reason for the
discrepancy between the two studies is not obvious, it is
clear that N-glycosylation is important for ASIC1a
regulation.
These data further imply that processes controlling
protein maturation through the secretory pathway play
critical roles in regulating ASIC function. Consistent
with this speculation, one report shows that most
ASIC1a is trapped in endoplasmic reticulum (ER) but
undergoes rapid membrane insertion in response to
serum deprivation [68]. In addition, glycerol, a common
reagent that facilitates protein maturation, increases
ASIC2 surface expression in vascular smooth muscle
cells [93]. Similar mechanisms may also regulate ASIC
biogenesis in disease conditions. In one study, MCAO
reduces ASIC1a expression levels within 30 minutes
[94]. Although it remains unclear whether ASIC1a traf-
ficking is affected in this paradigm, the result suggests
that altered ASIC biogenesis regulates ischemia-induced
neuronal injury. In addition, increased oxidation may
also regulate ASIC trafficking. H2O2, a reactive oxygen
species (ROS), reduces ASIC1a surface expression [95].
It will be interesting to see whether factors regulating
ER stress and/or ROS production regulate ASIC1a sur-
face and dendritic trafficking, and to ask how proteins
that control the secretory process affect ASIC trafficking
and function.
Motifs within ASICs
All ASICs contain a C-terminal PDZ binding motif.
The C-termini of ASIC1 and ASIC2 are DFTC and
EIAC, respectively, and more closely resemble that of
a type II motif [67,96,97]. In contrast, the last four
amino acid of ASIC3, VTRL, fits a canonical type I
motif [98]. Through the interaction with several PDZ
proteins, these motifs regulate ASIC surface expres-
sion, synaptic targeting, and channel function (see next
section). Another motif identified within the C-
terminus of ASIC1a is a LDDVK motif, which func-
tions as an α-actinin interacting motif [99]. Mutating
this motif has no apparent effect on ASIC1a surface
expression, but slight decreases the pH sensitivity of
ASIC1a. At the N-terminus, all ASICs contain a His-
Gly (HG) motif, which is a signature motif for EDA
family ion channels. In ENaCs, mutating the HG motif
reduces the open probability of these channels
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The functional significance of the HG motif in ASICs,
however, remains unclear. Other than these three
examples, we know little about motifs in ASICs. The
characterization of novel motifs within ASICs will help
us to understand molecular mechanisms regulating
these channels, facilitate the identification of new
ASIC interacting proteins, and also provide potential
sites for intervening acidosis-induced changes.
Proteins regulating ASICs
Through direct association or protein modification, ef-
fector proteins and/or signaling molecules regulate the
function of various ion channels. The number of ASIC-
regulators has kept increasing in the past few years. A
summary of these effector proteins and signaling mole-
cules is listed below.
Effector proteins
α-Actinin α-Actinin is one family of molecules import-
ant for linking the actin cytoskeleton with the synaptic
complex. Actinin-1 and −4 interact with ASIC1a
through a C-terminal LDDVK motif [99]. In heterol-
ogous cells, the interaction with actinin-4 but not that
with actinin-1 regulates ASIC1a current properties; pH
sensitivity and recovery from desensitization are
increased with actinin-4 overexpression. In hippocampal
neurons, knocking down actinin 1, 2 and 4 together
increases ASIC current density and reduces pH50 [99].
AKAP150 AKAP150 is the major AKAP for anchoring
PKA to synapses [102]. AKAP150 associates and co-
localizes with ASIC1a and ASIC2a, and increases
ASIC1a current [70]. The effect on current is likely due
to a PKA-dependent mechanism. Ht-31, a small peptide
that inhibits the association between PKA and
AKAP150, reduces acid-activated current in cultured
cortical neurons [70].
Annexin II light chain/p11 p11 is an adaptor protein
which forms a complex with Annexin II [103]. p11/
Annexin II complex interacts with multiple ion channels
and regulates their trafficking. p11 interacts with the N-
terminus of ASIC1a but not with other ASICs [104].
Through this interaction, p11 increases ASIC1a surface
expression and current density without changing other
properties of the current.
Chaperones Several chaperone proteins interact with
ASICs with different specificity. Hsp90 and Grp4 interact
with ASIC1a, Hsc70 interacts with ASIC2a, Grp78 and
calnexin interact with both ASIC1a and 2a [105]. Knock-
ing down Hsc70 increases ASIC2a surface expression in
both glioma and muscle cells [93,105]. The detailedmolecular mechanism for how chaperones affect ASIC
trafficking and function remains to be clarified.
CIPP (channel-interacting PDZ domain protein)
CIPP contains four PDZ domains. Through its fourth
PDZ, CIPP interacts with ASIC3 and increases its current
density [106]. This effect is most likely due to an increase
in the number of functional channels because CIPP
appears to have no effect on open probability or single
channel conductance of ASIC3.
Lin-7b Lin-7b associates with ASIC3 in COS cells [98].
This interaction increases surface expression and current
amplitude of ASIC3.
MAGI-1b MAGI-1b is a member of the MAGUK
(membrane-associated guanylate kinases) family. MAGI-
1b co-immunoprecipitates with ASIC3 in COS cells [98].
The functional effect of MAGI-1b on ASIC3 remains
unclear.
NHERF (Na+/H+ exchanger regulatory factor) Both
NHERF1 and NHERF2 interact with ASIC3 via PDZ
dependent interactions [107]. In COS cells, NHERF1
alters the distribution of ASIC3, which becomes coloca-
lized with the ezrin/radixin/moesin family proteins. The
interaction with NHERF1 increases surface expression,
peak amplitude and sustained current of ASIC3. In
addition, PKC enhances the association between
NHERF1 and ASIC3 through the phosphorylation of
serine 523 on ASIC3.
PICK1 (Protein-interacting with C-kinase) PICK1 is a
scaffolding protein that regulates the trafficking of mul-
tiple synaptic receptors [108]. PICK1 interacts with
ASIC1a and ASIC2 through the PDZ-dependent interac-
tions [67,96]. The interaction between PICK1 and
ASIC1a increases surface expression of ASIC1a, and this
effect depends upon the BAR domain and lipid binding
of PICK1 [109,110]. The interaction between ASIC1a
and PICK1 is regulated by protein kinase A (PKA) and
protein kinase C (PKC) (see below).
PIST PIST is a PDZ containing protein that was origin-
ally identified as an interactor with TC10, a Rho GTPase
[111]. PIST was identified as an ASIC3 interactor in a
two-hybrid screening. The functional effect of PIST on
ASIC3 is unknown [98].
PSD-95 (Postsynaptic density protein 95) PSD-95 is
the primary organizer of the postsynaptic density complex.
Through PDZ-dependent interactions, PSD-95 associates
with ASIC2a and ASIC3 but not ASIC1a [20,98]. In heter-
ologous cells, the interaction between PSD-95 and ASIC3
Zha Molecular Brain 2013, 6:1 Page 9 of 13
http://www.molecularbrain.com/content/6/1/1occurs in lipid rafts, and reduces surface expression and
current amplitude of ASIC3 [98,112]. In hippocampal
slices, PSD-95 is important for synaptic targeting of
ASIC2a, which in turn increases the synaptic levels
of ASIC1a and acidosis-induced [Ca2+]i responses in
spines [20].
Stomatin and Stomatin-like protein 3 (SLP3) Stoma-
tin and SLP3 co-immunoprecipitate with ASIC1a, 2a
and 3 in heterologous cells [113-115]. Dimerization of
stomatin is essential for its interaction with ASICs [116].
Stomatin has no effect on ASIC1a current, increases the
rate of desensitization of ASIC2a, and drastically reduces
ASIC3 current. SLP3, which forms a complex with both
stomatin and ASIC2a, reduces ASIC2a current without
affecting its surface expression. In the SLP3 knockout
mice, ASIC current is increased in parallel with a disrup-
tion of touch sensation.
Signaling molecules regulating ASICs
Ca2+/calmodulin-dependent protein kinase II (CaM-
KII) The C-terminus of ASIC1a contains a KRXS se-
quence, which can be phosphorylated by CaMKII and
PKA. CaMKII phosphorylation of ASIC1a increases its
current amplitude and probably contributes to ischemia-
induced neuronal death [86]. This finding also suggests
that conditions which alter [Ca2+]i levels play an active
role in regulating ASIC1a and consequently acidosis-
related processes. Interestingly, acidosis increases [Ca2+]i
via ASIC1a, and manipulating ASIC1a expression levels
regulates CaMKII phosphorylation [19]. These findings
suggest a possible positive feedback mechanism contribut-
ing to acidosis-induced changes in neural plasticity and
excitotoxicity.
Protein kinase A (PKA) PKA phosphorylates ASIC1a at
the same site as CaMKII. PKA phosphorylation of ASIC1a
inhibits its association with PICK1 and reduces the clus-
tering of ASIC1a inside the cell [117]. Further study is
needed to clarify how PKA regulates ASIC function in
neurons, and whether PKA and CaMKII share similar
mechanisms in regulating acidosis-induced changes.
Phosphoinositide 3-kinase (PI3K) Activation of PI3K
by BDNF results in increased surface expression of
ASIC1a and ASIC2a, but not that of ASIC1b or ASIC3
[89]. This effect was attributed to increased insertion as
opposed to a reduction in endocytosis of ASIC1a. The
serine 25 site in ASIC1a is important for the observed
effect. An ASIC1a S25A mutant has reduced surface ex-
pression and abolishes BDNF-induced increase in
current. Ser25 phosphorylation apparently contributes to
part of brain derived neurotrophic factor (BDNF)-
induced hypersensitivity to painful stimuli. These resultsestablish a connection between neutrophin signaling and
ASIC regulation. One remaining question is which kin-
ase directly phosphorylates the Ser25 site in ASIC1a,
which does not appear to fit the consensus phosphoryl-
ation sites of the common kinases.
Insulin signaling Insulin deprivation increases ASIC1a
surface trafficking and potentiates acid-activated cur-
rents [68]. Insulin initiates multiple downstream signal-
ing events, including the activation of PI3K/Akt pathway
[118]. However, since PI3K activation leads to increased
ASIC1a trafficking [89], the effect of insulin is most
likely mediated by an PI3K-independent pathway.
Protein kinase C (PKC) PKC regulates both ASIC1a
and ASIC2a. In Xenopus oocytes, PKC activation reduces
current amplitude of human ASIC1a [119]. Serine 40
and 499 appear to be involved. An S40E mutant shows
reduced current (mimics the effect of PKC), while an
S40A mutant abolishes the effect of PKC activators. Un-
like serine 40, both S499A and S499E show reduced
current amplitude, and S499A does not abolish the effect
of PKC activation. These effects on currents are unlikely
a result of reduced expression, because all mutants show
similar protein levels in the total membrane fraction.
However, it remains to see whether the surface traffick-
ing of ASIC1a is affected by PKC. In contrast to the
findings in oocytes, PKC increases ASIC current in cul-
tured cortical neurons [110]. This effect may due to
ASIC2. In COS cells, PKC activation increases ASIC2a
current [120]. Threonine 39 in ASIC2a, the equivalent of
serine 40 in ASIC1a, is important for the effect of PKC
on ASIC2a. In addition, the potentiation of ASIC current
by PKC depends upon an interaction with PICK1.
Reactive oxygen species (ROS) Many diseases increase
ROS production. Since ASICs contain a large number of
cysteines, several studies have studied whether redox
reagents affect ASIC channel properties. Reducing
reagents increase ASIC1a current while oxidizing
reagents have the opposite effect [88,121,122]. These
effects are largely due to modifications in the extracellu-
lar domain. In contrast to oxidizing reagents, nitric
oxide (NO) potentiates ASIC1a, -1b, -2a, and −3
through the modulation of extracellular domain [123].
In addition, ROS can target intracellular C-terminal
cysteines. H2O2 induces the formation of intersubunit
disulfide bonds between C-terminal cysteines within
ASIC1a, and reduces its surface expression [95].
Summary and speculations
Research in recent years has demonstrated that acidosis
and ASICs are an important contributor to multiple
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ASICs in diseases, it is now necessary to answer some
fundamental questions regarding the regulation and
function of ASICs. A few of these questions are dis-
cussed in this review and/or summarized below:
 What is the contribution of ASICs to synaptic
transmission?
 What is the dynamics of acidosis-induced synaptic
remodeling?
 How do acidosis and ASICs contribute to synaptic
plasticity in diseases?
 Are there endogenous ASIC ligands other than
protons?
 How does the exact channel stoichiometry affect
ASIC function? For exmaple, are channels containing
1 ASIC1a and 2 ASIC2a subunits behave the same
as channels containing 2 ASIC1a and 1 ASIC2a? Or
do the heteromeric channels prefer one
stoichiometry over another?
 What is the role of altered ASIC trafficking in
synaptic remodeling and diseases?
 What novel motifs and accessory proteins contribute
to ASIC regulation?
 What signaling pathways regulate ASIC trafficking
and function?
The list apparently can go on longer. However, these
are some of the basic ones on ASIC biology. Answering
these questions will bring novel insight into the regula-
tion of ASICs and their role in neuron physiology, and
will lay the groundwork for targeting these ion channels
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